Perpetua Medical AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	16.92	14.56	6.94	9.94	10.11	8.82
Revenue Growth (YoY)	79.20%	109.83%	-30.16%	-1.76%	14.73%	363.72%
Cost of Revenue	7.58	6.96	3.8	4.09	3.47	2.89
Gross Profit	9.34	7.6	3.14	5.85	6.65	5.93
Selling, General & Admin	17.58	14.89	10.94	23.78	25.56	19.37
Other Operating Expenses	-11.83	-11.83	-5.66	0.38	-0.19	-0.14
Operating Expenses	9.15	5.56	5.6	24.34	25.76	19.61
Operating Income	0.19	2.04	-2.46	-18.49	-19.11	-13.68
Interest Expense	-0.8	-0.7	-0.08	-0.07	-0.13	-0.15
Interest & Investment Income	0.32	0.08	0.29	0.29	0.07	0.12
Other Non Operating Income (Expenses)	-0	0	-	-	-0	-
EBT Excluding Unusual Items	-0.29	1.42	-2.24	-18.28	-19.16	-13.71
Gain (Loss) on Sale of Assets	-0.23	-0.23	0.04	-	-	-
Pretax Income	-0.52	1.19	-2.2	-18.28	-19.16	-13.71
Income Tax Expense	-0.2	-0.02	0.18	-	-	-
Earnings From Continuing Operations	-0.32	1.22	-2.38	-18.28	-19.16	-13.71
Minority Interest in Earnings	2.02	1.24	-0.09	-	-	-
Net Income	1.7	2.45	-2.47	-18.28	-19.16	-13.71
Net Income to Common	1.7	2.45	-2.47	-18.28	-19.16	-13.71
Shares Outstanding (Basic)	5	5	4	2	1	1
Shares Outstanding (Diluted)	5	5	4	2	1	1
Shares Change (YoY)	10.60%	9.65%	145.32%	153.20%	20.61%	20.91%
EPS (Basic)	0.34	0.53	-0.58	-10.56	-28.03	-24.18
EPS (Diluted)	0.34	0.53	-0.58	-10.56	-28.03	-24.18
Free Cash Flow	-6.5	-6.53	-7.03	-16.41	-19.65	-15.84
Free Cash Flow Per Share	-1.29	-1.40	-1.66	-9.48	-28.74	-27.94
Gross Margin	55.21%	52.21%	45.27%	58.85%	65.72%	67.26%
Operating Margin	1.14%	14.04%	-35.39%	-186.11%	-188.94%	-155.22%
Profit Margin	10.04%	16.84%	-35.64%	-183.94%	-189.48%	-155.54%
Free Cash Flow Margin	-38.38%	-44.87%	-101.27%	-165.16%	-194.31%	-179.68%
EBITDA	3.32	4.54	-2.13	-18.31	-18.72	-13.3
EBITDA Margin	19.60%	31.21%	-30.73%	-184.31%	-185.10%	-150.87%
D&A For EBITDA	3.12	2.5	0.32	0.18	0.39	0.38
EBIT	0.19	2.04	-2.46	-18.49	-19.11	-13.68
EBIT Margin	1.14%	14.04%	-35.39%	-186.11%	-188.94%	-155.22%
Revenue as Reported	28.87	26.51	14.15	9.98	10.42	9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.